Loading the map…

General medical practice activities · Belfast

Fy Focus

Fy Focus Ltd

Turned to net liabilitiesActiveLatest figures: 2025Abridged accountsCompany only3 years on the register

Private limited company registered in Belfast, classed under “General medical practice activities”.

Headline figures

FY to May 2025 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

What the numbers say

1 finding from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£20242025
Profit after tax—
Turnover
Net assets
Cash
Employees

Every figure for all 2 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

Balance sheet and ratios

From the filed balance sheets · £

Balance sheet20242025
Fixed assets
Current assets
Creditors due within a year
Net current assets
Net assets
Ratios
Current ratioCurrent assets for every £1 owed within a year
Creditors to assetsEverything owed to creditors as a share of fixed plus current assets

5 balance-sheet lines and 2 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Questions people ask

›What does Fy Focus do?

Private limited company registered in Belfast, classed under “General medical practice activities”.

›How much turnover does Fy Focus make?

Answered in the full report

›Is Fy Focus profitable?

Fy Focus's profit isn't public: small companies may file without a profit and loss account.

›How many people work at Fy Focus?

Answered in the full report

›Where is Fy Focus based?

Its registered office is Apartment 1 Windsor Manor Mews, 3-5 Windsor Avenue, Belfast, BT9 6EE, in Belfast.

›When was Fy Focus founded?

Fy Focus Ltd was incorporated on 12 May 2023.

›Is Fy Focus still trading?

The register lists Fy Focus Ltd as active.